Home » Newsletters » BioWorld Science

BioWorld Science

April 21, 2006

View Archived Issues

Studies assess pharmacodynamics, mechanism of action of ceftobiprole

Studies assess cancer prevention with selenium compounds

Schering-Plough selects compound for metabolic disease from collaboration

Reata licenses tricyclic bis-enones antiinflammatory compounds

Cytokinetics studies SB-743921 for NHL

PhG-alpha1 delays establishment and growth of colorectal cancer tumors in mice

Positive results for CRx-170 in proof-of-concept asthma study

Schering AG Boards recommend acceptance of Bayer offer

Isis licenses HIV inhibitor ISIS-5320 to ImQuest

Technosphere Insulin System improves HbA1c in phase II study

Schering-Plough updates status of phase II study of SCH-503034

Chiron shareholders approve acquisition by Novartis

Nonapprovable letter for Hexvix NDA

New compound class from Trubion Pharmaceuticals for B-cell chronic lymphocytic leukemias

PRX-08066 reduces systolic pulmonary blood pressure in study

Antitumor efficacy of new CD40 agonist antibody

Vesicare approved as first drug for overactive bladder in Japan

Funguard approved for use in children in Japan

Chugai seeks Japanese approval for Avastin in colorectal cancer

Japanese approval for Cetrotide for premature ovulation

New treatments for cancer covered in recent patents

Zometa receives new approval in Japan

AmBisome receives Japanese approval

Feron approved in Japan for compensatory cirrhosis C

Japanese approval for Nu-Lotan in diabetic nephropathy

HIV integrase inhibitors claimed in recent Pfizer patent

Novel cathepsin K inhibitor as a potential antiresorptive agent to treat osteoporosis

Synthesis and in vitro evaluation of new potent GAR Tfase inhibitor

Multinational phase III study shows positive results for panitumumab in metastatic colorectal cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...